{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 19611
    }
  },
  "results": [
    {
      "safetyreportversion": "1",
      "safetyreportid": "10004316",
      "primarysourcecountry": "US",
      "occurcountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20141002",
      "reporttype": "1",
      "serious": "2",
      "receivedateformat": "102",
      "receivedate": "20140312",
      "receiptdateformat": "102",
      "receiptdate": "20140312",
      "fulfillexpeditecriteria": "2",
      "companynumb": "US-009507513-1403USA004864",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "MERCK",
        "duplicatenumb": "US-009507513-1403USA004864"
      },
      "primarysource": {
        "reportercountry": "US",
        "qualification": "3"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "49",
        "patientonsetageunit": "801",
        "patientsex": "1",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Lip blister",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Pyrexia",
            "reactionoutcome": "6"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "PEGINTRON",
            "drugauthorizationnumb": "103949",
            "drugstructuredosagenumb": ".5",
            "drugstructuredosageunit": "012",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "803",
            "drugdosagetext": "0.5 ML, QW",
            "drugdosageform": "POWDER FOR INJECTION",
            "drugadministrationroute": "058",
            "drugindication": "HEPATITIS C",
            "drugstartdateformat": "102",
            "drugstartdate": "20140222",
            "actiondrug": "4"
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "REBETOL",
            "drugstructuredosagenumb": "600",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "2",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosagetext": "600 MG, BID",
            "drugdosageform": "CAPSULE",
            "drugadministrationroute": "048",
            "drugindication": "HEPATITIS C",
            "drugstartdateformat": "102",
            "drugstartdate": "20140222",
            "actiondrug": "4"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "SOVALDI",
            "drugstructuredosagenumb": "400",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosagetext": "400 MG, QD",
            "drugrecurreadministration": "3",
            "openfda": {
              "application_number": [
                "NDA204671",
                "NDA212480"
              ],
              "brand_name": [
                "SOVALDI"
              ],
              "generic_name": [
                "SOFOSBUVIR"
              ],
              "manufacturer_name": [
                "Gilead Sciences, Inc."
              ],
              "product_ndc": [
                "61958-1501",
                "61958-1503",
                "61958-1504",
                "61958-1505"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "SOFOSBUVIR"
              ],
              "rxcui": [
                "1484916",
                "1484922",
                "2203891",
                "2203893",
                "2203993",
                "2203999",
                "2204090",
                "2204092"
              ],
              "spl_id": [
                "74c52ec6-8358-4e63-b299-64ec1ff7f434"
              ],
              "spl_set_id": [
                "80beab2c-396e-4a37-a4dc-40fdb62859cf"
              ],
              "package_ndc": [
                "61958-1501-1",
                "61958-1503-1",
                "61958-1504-1",
                "61958-1505-1"
              ],
              "nui": [
                "N0000191493",
                "N0000191258"
              ],
              "pharm_class_epc": [
                "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]"
              ],
              "pharm_class_moa": [
                "RNA Replicase Inhibitors [MoA]"
              ],
              "unii": [
                "WJ6CA3ZU8B"
              ]
            }
          }
        ]
      }
    }
  ]
}